Literature DB >> 21513938

Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation-- a nation wide database analysis.

Lian-Yu Lin1, Chang-Hsing Lee, Chih-Chieh Yu, Chia-Ti Tsai, Ling-Pin Lai, Juey-Jen Hwang, Pau-Chung Chen, Jiunn-Lee Lin.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is a risk factor for ischemic stroke. Stroke-prevention strategies based on risk schemes have been developed but most of the data are from western people. Our goal is to investigate the risk factors of ischemic stroke in Taiwanese with AF in a nation-wide database.
METHODS: A universal national health insurance (NHI) program has been implemented in Taiwan since 1995. We used system sampling database from 1997 to 2008 with a total of 1,000,000 subjects. By using ambulatory and inpatient claim data, we included subjects with AF and were above 20 years old. We excluded those who had ever taken warfarin or aspirin or had valvular heart diseases. RESULT: A total of 7920 patients (3633 women, 4287 men) were included in the final analyses. Cox regression analysis showed that the risk factors for ischemic stroke were age (OR=1.338 for age 65-74 years vs. age 20-64 years, P=0.014; OR=1.652 for age over 75 years vs. age 20-64 years, P<0.001), hypertension (HTN) (OR=2.656, P<0.001), diabetes mellitus (DM) (OR=1.341, P=0.005), heart failure (OR=1.611, P<0.001), previous ischemic stroke or transient ischemic accident (TIA) (OR=2.752, P<0.001) and peripheral arterial disease (PAD) (OR=1.814, P=0.006). The gender, coronary artery disease, history of myocardial infarction and chronic renal insufficiency were not associated with ischemic stroke. The rate of ischemic stroke was much lower in current cohort as compared with that in whites. Frequent used risk schemes including CHADS₂ and CHA₂DS₂-VASC had comparable but only limited ability to predict ischemic stroke in subjects with AF.
CONCLUSION: Compare with western people, hypertension plays a more important role in ischemic stroke in Taiwanese with AF and the incidence is lower. A substantial number of ischemic strokes cannot be accurately predicted by current risk schemes.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21513938     DOI: 10.1016/j.atherosclerosis.2011.03.033

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  29 in total

Review 1.  Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.

Authors:  Wen-Gen Zhu; Qin-Mei Xiong; Kui Hong
Journal:  Tex Heart Inst J       Date:  2015-02-01

2.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Insomnia and the Risk of Atrial Fibrillation: A Population-Based Cohort Study.

Authors:  Hsiu-Hao Lee; Yueh-Chung Chen; Jien-Jiun Chen; Shih-Hsiang Lo; Yue-Liang Guo; Hsiao-Yun Hu
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

Review 4.  Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup.

Authors:  Thomas F Deering
Journal:  J Atr Fibrillation       Date:  2017-04-30

Review 5.  AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

Authors:  Nasir Shariff; Abdul Aleem; Mukesh Singh; Yuan Z Li; Stacey J Smith
Journal:  J Atr Fibrillation       Date:  2012-10-06

6.  Eastern promises: Additive role of metabolic syndrome for thromboembolic risk stratification in Taiwanese atrial fibrillation patients.

Authors:  Sanjay Dixit; Vinay Kini
Journal:  Heart Rhythm       Date:  2013-12-04       Impact factor: 6.343

Review 7.  Stroke And Bleeding Risk Assessment: Where Are We Now?

Authors:  Mikhail S Dzeshka; Gregory Y H Lip
Journal:  J Atr Fibrillation       Date:  2014-04-30

8.  Areca nut chewing and risk of atrial fibrillation in Taiwanese men: a nationwide ecological study.

Authors:  Wei-Chung Tsai; Chung-Yu Chen; Hsuan-Fu Kuo; Ming-Tsang Wu; Wei-Hua Tang; Chih-Sheng Chu; Tsung-Hsien Lin; Ho-Ming Su; Po-Chao Hsu; Shih-Jie Jhuo; Ming-Yen Lin; Kun-Tai Lee; Sheng-Hsiung Sheu; Wen-Ter Lai
Journal:  Int J Med Sci       Date:  2013-04-25       Impact factor: 3.738

9.  Newly diagnosed atrial fibrillation is an independent factor for future major adverse cardiovascular events.

Authors:  Chen-Yu Li; Chia-Pin Lin; Yu-Sheng Lin; Lung-Sheng Wu; Chee-Jen Chang; Pao-Hsien Chu
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

10.  Risk of bleeding and stroke with oral anticoagulation and antiplatelet therapy in patients with atrial fibrillation in Taiwan: a nationwide cohort study.

Authors:  Pei-Chun Chen; Gregory Y H Lip; Grace Yeh; Hung-Ju Lin; Kuo-Liong Chien
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.